Braunwald's Heart Disease: Review and Assessment. Text with Access Code (Expert Consult)

Lilly, Leonard S. MD

Book Information
Edition:	11th
Publisher:	Elsevier Science Publishing Company
ISBN:	0-323-54634-X (032354634X)
ISBN-13:	978-0-323-54634-8 (9780323546348)
New Edition:	0-323-83513-9
Old Edition:	0-323-34134-9
Format:	Examination Question
Binding:	with Supplement Softcover + Internet Access Code
Copyright:	2019
Publish Date:	09/18
Weight:	1.72 Lbs.
Pages:	298
Subject Class:	REV (Medical Exam and Class Reviews)
Remarks:	A New Edition of this Title is Available
Return Policy:	Returns accepted up to 10 months provided no other recalls or return restrictions apply. This product contains software or Internet access code(s). Returns are not accepted if seal is broken or if access code revealed.
Contributing Authors:	View

Class Specifications
Discipline:	Cardiovas Sys
Subject Definition:	Heart Diseases-Examination Questions
NLM Class:	WG 18.2
LC Class:	RC681
Abstract:	With more than 700 review questions derived from and keyed to the newly revised 11th Edition of Braunwald's Heart Disease, Braunwalds Heart Disease Review and Assessment, 11th Edition, is the perfect review tool for fellows, residents, and practitioners to prepare for board exams in cardiovascular medicine. Noted Harvard educator Dr. Leonard S. Lilly, with assistance from faculty and fellows at Brigham & Womens Hospital, provides a thorough, clear, and concise overview of the entire field, helping ensure your mastery of all key aspects of todays cardiology. This title is a one-stop resource for complete, authoritative coverage of the most important concepts in cardiovascular medicine . ideal for self-assessment, individualized study, and clinical practice. ...Uses a completely reorganized format throughout, matching the reorganization of Braunwalds Heart Disease, 11th Edition. ...Provides new coverage of biomarkers and their use in precision medicine, cardio-oncology, sleep disordered breathing and CVD, the latest hypertension guidelines, reversal agents for the novel oral anticoagulants, and diabetes medications with recently proven cardiovascular benefits.

Follow Matthews Book Co. on: